31-45 of 469
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Integrating Weight Management Into Comprehensive Asthma Care
Clinician's RoundtableIntegrating Weight Management Into Comprehensive Asthma Care
Anne Dixon, MD
Obesity and Asthma: Intersecting Pathways and Real-World Impacts
Clinician's RoundtableObesity and Asthma: Intersecting Pathways and Real-World Impacts
Anne Dixon, MD
MASLD and MASH in Focus: Clinical Priorities and Promising Pathways
Clinician's RoundtableMASLD and MASH in Focus: Clinical Priorities and Promising Pathways
Peter Buch, MD, FACG, AGAF, FACP
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
- advertisement
MASLD Explained: A Modern Framework for a Multisystem Condition
Clinician's RoundtableMASLD Explained: A Modern Framework for a Multisystem Condition
Peter Buch, MD, FACG, AGAF, FACP
Unveiling the Role of Obesity in MASLD Progression
Clinician's RoundtableUnveiling the Role of Obesity in MASLD Progression
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
Clinician's RoundtableNew Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
From Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity
Clinician's RoundtableFrom Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity
Hallie Blevins, PhD
Assessing the Role of Metabolic Factors in Psoriasis Management
AudioAbstractsAssessing the Role of Metabolic Factors in Psoriasis Management
Ryan Quigley
AIP Emerges as a Potential Marker for Diabetic Kidney Risk
Clinician's RoundtableAIP Emerges as a Potential Marker for Diabetic Kidney Risk
- advertisement
Pediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
On the Frontlines of PsoriasisPediatric Psoriasis in Focus: Emerging Insights on Immune and Obesity Drivers
Charles Turck, PharmD, BCPS, BCCCP
Amy Paller, MS, MD
Linking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Clinician's RoundtableLinking Obesity to Alzheimer’s: The Lipid Signals Driving Neurodegeneration
Stephen Wong, PhD
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Ryan Quigley